Fundraising Fox
Port Therapeutics
Founded 2021 · 5 employees on LinkedIn · 1 known investors
Find your way into Port Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
452 people can intro you to Steve
Ask Wendy Perrow to introduce you to Steve Altschuler
You →Wendy · together at AsclepiX Therapeutics, Inc. →Steve
Sign up to find every way you can get introduced to Port Therapeutics
- Your email: who you already know at Port Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Port Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Port Therapeutics is a company focused on cancer immunotherapy development.
Founders & leadership
SA
Steve AltschulerExecutive ChairDr. Altschuler is Managing Director of Healthcare Ventures at Ziff Capital Partners, where he focuses on machine learning applications in cellular and molecular sciences. He cofounded Spark Therapeutics, which he chaired through its public offering and development of the first FDA- and EMA-approved gene therapy (Luxturna); Spark was acquired by Roche for $4.8B in 2019.
Investors · 1
Founder mafia
2 people who came through Port Therapeutics went on to found or lead other companies.
Frequently asked questions
- What does Port Therapeutics do?
- Port Therapeutics is a company focused on cancer immunotherapy development.
- Who are Port Therapeutics's investors?
- Port Therapeutics's investors include Catalio Capital Management, LP.